These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Developmental delay in fetal aminopterin/methotrexate syndrome. Del Campo M; Kosaki K; Bennett FC; Jones KL Teratology; 1999 Jul; 60(1):10-2. PubMed ID: 10413333 [TBL] [Abstract][Full Text] [Related]
28. Folic-acid antagonists in psoriasis. Br Med J; 1966 May; 1(5499):1313. PubMed ID: 5934371 [No Abstract] [Full Text] [Related]
29. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action. Rumberger BG; Barrueco JR; Sirotnak FM Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741 [TBL] [Abstract][Full Text] [Related]
30. FURTHER OBSERVATIONS OF THE BINDING AND INHIBITION OF DIHYDROFOLIC REDUCTASE BY FOLIC ACID ANTAGONISTS. SCHRECKER AW; HUENNEKENS FM Biochem Pharmacol; 1964 May; 13():731-42. PubMed ID: 14181276 [No Abstract] [Full Text] [Related]
31. [CYTOSTATIC DRUGS IN THE TREATMENT OF PSORIASIS. WITH SPECIAL REFERENCE TO THE ORAL USE OF AMINOPTERIN]. WEREIDE K Tidsskr Nor Laegeforen; 1964 Oct; 84():1323-7. PubMed ID: 14230476 [No Abstract] [Full Text] [Related]
32. SOME EFFECTS OF FOLIC ACID ANTAGONISTS ON VIRUS INDUCED CHICKEN ERYTHROLEUKAEMIA. STENKVIST B; PONTEN J Acta Pathol Microbiol Scand; 1964; 61():46-54. PubMed ID: 14150633 [No Abstract] [Full Text] [Related]
33. Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias. Norris RE; Adamson PC Cancer Chemother Pharmacol; 2010 May; 65(6):1125-30. PubMed ID: 19784838 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues. Stone SR; Montgomery JA; Morrison JF Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748 [TBL] [Abstract][Full Text] [Related]
35. [Psoriasis. treatment by aminopterin and methotrexate]. RAVINA A Annee Ther; 1962; 33():44-6. PubMed ID: 13990834 [No Abstract] [Full Text] [Related]
36. Syntheses and antifolate activity of 5-methyl-5-deaza analogues of aminopterin, methotrexate, folic acid, and N10-methylfolic acid. Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Sirotnak FM J Med Chem; 1986 Jun; 29(6):1080-7. PubMed ID: 2423690 [TBL] [Abstract][Full Text] [Related]
37. The influence of folate antagonists on the metabolism of folic acid and its reduced derivatives in rat liver and kidney. Bühring U; Shin YS; Fölsch E Cancer Res; 1977 Jan; 37(1):299-304. PubMed ID: 830415 [TBL] [Abstract][Full Text] [Related]
39. Chromosomal abnormalities produced by folic acid antagonists. Ryan TJ; Boddington MM; Spriggs AI Br J Dermatol; 1965 Nov; 77(11):541-55. PubMed ID: 5853249 [No Abstract] [Full Text] [Related]
40. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]